Table of Contents
Current Retatrutide Availability Status (2026)
⏳ NOT YET AVAILABLE
Retatrutide is currently in Phase 3 clinical trials and has NOT been approved by the FDA. It is legally available ONLY to participants in Eli Lilly's authorized clinical trials.
When Will Retatrutide Be Available Through Providers?
📊 Q2-Q4 2026: Phase 3 Trial Results
Eli Lilly expects to report results from 7 Phase 3 trials throughout 2026 (obesity + type 2 diabetes indications).
📋 Q4 2026: FDA Submission
If Phase 3 trials are successful, Eli Lilly will submit New Drug Application (NDA) to FDA.
✅ Best Case: Q4 2026 | Realistic: Q2-Q3 2027
Retatrutide will be available through US providers sometime between Q4 2026 and Q3 2027.
Telehealth Providers That Will Likely Offer Retatrutide
Based on current GLP-1 telehealth landscape, here are the companies most likely to offer retatrutide once FDA-approved:
Medvi (HIGH LIKELIHOOD)
Medvi is one of the most aggressive telehealth providers for GLP-1 peptides. Currently offers tirzepatide and semaglutide at competitive pricing ($179-369/month).
Current Tirzepatide Pricing: $179/mo
First month with $120 discount • After: $299/mo
Predicted Retatrutide Pricing: $399-549/month once available
Start Tirzepatide Now with Medvi →Ro (HIGH LIKELIHOOD)
Major telehealth provider with comprehensive weight loss program. Offers both tirzepatide and semaglutide.
Current Tirzepatide Pricing: $349/mo
Predicted Retatrutide Pricing: $499-649/month once available
Start Tirzepatide Now with Ro →Remedy Meds (HIGH LIKELIHOOD)
Premium service with fast turnaround times and personalized support.
Current Tirzepatide Pricing: $299-399/mo
Predicted Retatrutide Pricing: $449-599/month once available
Start Tirzepatide Now with Remedy Meds →Insurance Coverage & Cost Expectations
| Scenario | Expected Monthly Cost |
|---|---|
| Retail (No Insurance) | $1,000-1,500 |
| Telehealth (Cash Pay) | $400-700 |
| Insurance (with PA) | $100-300 |
| Manufacturer Savings Card | $25-50 |
Legal Alternatives to Retatrutide (Available NOW)
Instead of waiting 1-2 years for retatrutide approval, start losing weight TODAY with these FDA-approved alternatives:
Medvi
$179/mo
Tirzepatide • First month (save $120)
- 15-22.5% weight loss
- FDA-approved
- Cancel anytime
Remedy Meds
$299/mo
Tirzepatide • Premium
- 15-22.5% weight loss
- Fast turnaround
- Personalized support
Ro
$349/mo
Tirzepatide or Semaglutide
- Choose your peptide
- Comprehensive program
- Medical supervision
Don't Wait 1-2 Years for Retatrutide
Start losing weight TODAY with FDA-approved tirzepatide. 15-22.5% weight loss available NOW.
Get Started with Medvi ($179/mo) →